918²©ÌìÌÃ

±»ºöÊÓµÄÒÖÓôÖ¢Ö¢×´£¬£¬£¬£¬£¬ÕâЩÈÏÖªÖ¢×´ÐèСÐÄ£¡

ʱ¼ä£º

2024-10-11

±»ºöÊÓµÄÒÖÓôÖ¢Ö¢×´£¬£¬£¬£¬£¬ÕâЩÈÏÖªÖ¢×´ÐèСÐÄ£¡

 

ÒÖÓôÖ¢(major depressive disorder£¬£¬£¬£¬£¬MDD)ÊǾ«ÉñÕÏ°­µÄ³£¼ûÀàÐÍ£¬£¬£¬£¬£¬ÆäÁÙ´²ÌåÏÖ°üÀ¨ÇéÐ÷Ö¢×´¡¢ÇûÌåÖ¢×´ºÍÈÏÖªÖ¢×´3¸öά¶È£¬£¬£¬£¬£¬³£»£»áÔì³É²î±ðˮƽµÄ¹¦Ð§Ë𺦣¬£¬£¬£¬£¬Ó°Ï컼ÕßµÄÊÂÇ顢ѧϰºÍÉç»áÉúÑÄ¡£¡£¡£¡£Öйú¾«ÉñÎÀÉúÊÓ²ìÏÔʾÎÒ¹úÒÖÓôÕÏ°­ÖÕÉú»¼²¡ÂÊΪ6.8%[1] £¬£¬£¬£¬£¬×Ü»¼²¡ÈËÊýÁè¼Ý9000Íò¡£¡£¡£¡£

        ÆäÖУ¬£¬£¬£¬£¬ÈÏÖªÖ¢×´Ö÷ÒªÌåÏÖΪִÐй¦Ð§¡¢×¢ÖØÁ¦¡¢Ó°ÏóÁ¦¡¢ÐÅÏ¢¼Ó¹¤ËÙÂʵȷ½ÃæµÄ¹¦Ð§ÊÜË𡣡£¡£¡£Ïà±ÈÓÚ¶ÔÇéÐ÷Ö¢×´£¨ÈçÇéÐ÷½µµÍ£©¡¢ÇûÌåÖ¢×´£¨ÈçʧÃß¡¢ÌåÖؼõÇᡢʳÓû¼õÍË£©µÄÏàʶ£¬£¬£¬£¬£¬ÒÖÓôÖ¢ÈÏÖªÖ¢×´ÍùÍùÊDZ»ºöÊӵı£´æ£¬£¬£¬£¬£¬ÀýÈç˼Ë÷¼°¼¯ÖÐ×¢ÖصÄÄÜÁ¦Ï½µ¡¢ÄÑÒÔ×ö³ö¾öÒéµÈ£¬£¬£¬£¬£¬¶¼ÊÇÒÖÓôÖ¢µÄÁÙ´²ÌåÏÖÖ®Ò»[2] ¡£¡£¡£¡£

ÒÖÓôÖ¢µÄ

ÈÏÖªÖ¢×´

ÈÏÖªÖ¢×´Æձ鱣´æÓÚÒÖÓôÖ¢»¼ÕßÖУ¬£¬£¬£¬£¬¹á´®ÓÚÒÖÓô֢ȫ²¡³Ì£¬£¬£¬£¬£¬¿É·ºÆðÓÚÒÖÓôÖ¢ÒÖÓô±¬·¢Ç°ÇýÆÚ¡¢¼±ÐÔ±¬·¢ÆÚ£¨±¬·¢ÂÊ76.9%~94.0%£©¼°»º½âÆÚ£¨±¬·¢ÂÊ32.4%~44.0%£©[3] ¡£¡£¡£¡£

 

À´×ÔºÉÀ¼µÄÒ»ÏîΪÆÚ3ÄêµÄÇ°Õ°ÐÔÑо¿£¬£¬£¬£¬£¬¹²ÄÉÈë267ÀýÒÖÓôÖ¢»¼Õߣ¬£¬£¬£¬£¬ÊÓ²ìÒÖÓôÖ¢²ÐÁôÖ¢×´ÔÚÒÖÓôÖ¢±¬·¢ÆÚ»ººÍ½âÆڵı£´æÇéÐΡ£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬ÔÚÒÖÓôÖ¢±¬·¢ÆÚ£¬£¬£¬£¬£¬ÈÏÖªÖ¢×´·Ç¾­³£¼û£¬£¬£¬£¬£¬½ö´ÎÓÚÇéÐ÷½µµÍ/ÐËȤ¼õÍË£»£»ÔÚÒÖÓôÖ¢»º½âÆÚ£¬£¬£¬£¬£¬ÈÏÖªÖ¢×´ÊÇÒÖÓôÖ¢×î³£¼ûµÄ²ÐÁôÖ¢×´£¬£¬£¬£¬£¬ÊÇÇéÐ÷½µµÍ/ÐËȤ¼õÍ˵Ä2±¶[4] ¡£¡£¡£¡£

Ñо¿·¢Ã÷£¬£¬£¬£¬£¬×ÝÈ»ÇéÐ÷Ö¢×´ÒÑÍêÈ«»ò²¿·Ö»º½âµÄÒÖÓôÖ¢»¼Õߣ¬£¬£¬£¬£¬ÈÏÖª¹¦Ð§ÕÏ°­ÈÔ±£´æ£¬£¬£¬£¬£¬»¼Õ߻ᷢÃ÷×Ô¼º×¢ÖØÁ¦²»¼¯ÖС¢Ó°ÏóÁ¦²»¼Ñ¡¢Ö´ÐÐÁ¦²»Ç¿£¬£¬£¬£¬£¬ÈÏÖª¹¦Ð§Ã»ÓлñµÃ»Ö¸´£¬£¬£¬£¬£¬Ó°ÏìÊÂÇéЧÂʼ°ÈÕ³£ÉúÑÄ£¬£¬£¬£¬£¬µ¼Ö²¿·ÖÒÖÓôÖ¢»¼ÕßÄÑÒÔ»Ö¸´Õý³£Éç»á¹¦Ð§¡¢ÍêÈ«¿µ¸´£¬£¬£¬£¬£¬»¹¿ÉÄÜ»áÔöÌíÒÖÓôÖ¢µÄ¸´È¼¼°¸´·¢µÄ·çÏÕ¡£¡£¡£¡£

 

2019ÄêÁøÒ¶µ¶ÔÓÖ¾½ÒÏþµÄһƪÜöÝÍÆÊÎöÖÐÌáµ½£¬£¬£¬£¬£¬×¢ÖØÁ¦¡¢ÊÂÇéÓ°ÏóºÍºã¾ÃÓ°ÏóµÄȱÏÝÔÚÖØÐÔÒÖÓô±¬·¢»º½âºóÒ»Á¬±£´æ£¬£¬£¬£¬£¬²¢ÇÒÕâЩÈÏÖªÖ¢×´»áËæ×ÅÒÖÓôÖ¢Öظ´±¬·¢¶ø¶ñ»¯[5]¡£¡£¡£¡£1Ïî¹ØÓÚÒÖÓôÖ¢»º½âÆÚÈÏÖª¹¦Ð§µÄÑо¿ÏÔʾ£¬£¬£¬£¬£¬30£¥µÄ»¼ÕßÔÚÒÖÓôÖ¢×´µÖ´ïÁÙ´²»º½âºóÈÔÈ»ÓÐ×¢ÖØÁ¦²»¼¯ÖС¢Ó°ÏóÁ¦²îµÈÍ»³öÎÊÌâ[6]¡£¡£¡£¡£

 

¡¶ÖйúÒÖÓôÕÏ°­·ÀÖÎÖ¸ÄÏ¡·(µÚ¶þ°æ) Ã÷È·Ö¸³ö£¬£¬£¬£¬£¬ÒÖÓôÖ¢ÀÖ³ÉÖÎÁƵÄÒªº¦ÔÚÓÚ³¹µ×Ïû³ýÁÙ´²Ö¢×´£¬£¬£¬£¬£¬ïÔÌ­¸´·¢·çÏÕ£»£»Ìá¸ßÉúÑÄÖÊÁ¿£¬£¬£¬£¬£¬»Ö¸´Éç»á¹¦Ð§£¬£¬£¬£¬£¬µÖ´ïÕæÕýµÄÁÙ´²ÖÎÓú[7]¡£¡£¡£¡£Õâ¾ÍÒªÇóÒÖÓôÖ¢·ÀÖÎÐèÖØÊÓÈÏÖªÖ¢×´µÄ¸ÉÔ¤¡£¡£¡£¡£

 

ÁøÒ¶µ¶ÔÓÖ¾½ÒÏþµÄ1ÏîÄÉÈë1008ÀýÒÖÓôÖ¢»¼ÕߵĹú¼Ê´ó¹æÄ£Ëæ»ú±ÈÕÕÑо¿ÏÔʾ£¬£¬£¬£¬£¬¾­ÓÉΪÆÚ8ÖܵÄÖÎÁÆ£¬£¬£¬£¬£¬°¬Ë¾Î÷̪ÆÕÀ¼¡¢ÉáÇúÁÖ¼°ÎÄÀ­·¨ÐÁ¾ùÎÞ·¨ÓÐÓøÄÉÆÒÖÓôÖ¢»¼ÕßµÄÈÏÖªÖ¢×´[8]¡£¡£¡£¡£

 

Ò»ÏîÍøÂçÜöÝÍÆÊÎö£¬£¬£¬£¬£¬Í¨¹ýÊý¾Ý¿â¡¢ÁÙ´²ÊÔÑé×¢²áÖÐÐĺÍÏà¹Ø¾Û»áÕªÒªÒÔÆÀ¹ÀÖÖÖÖ¿¹ÒÖÓôÒ©¶ÔÈÏÖªÖ¢×´µÄ¸ÄÉÆÇéÐΣ¬£¬£¬£¬£¬Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬·üÁòÎ÷Í¡¶ÔÒÖÓôÖ¢»¼ÕßÈÏÖªÖ¢×´µÄ¸ÄÉÆÏÔÖøÓÅÓÚο½å¼Á[9]¡£¡£¡£¡£

·üÁòÎ÷Í¡¶ÔÒÖÓôÖ¢ÈÏÖªÖ¢×´

µÄÆð¾¢×÷ÓÃ

·üÁòÎ÷Í¡ÊÇÒ»ÖÖ¶à°Ðµã¡¢¶àģʽµÄÐÂÐÍ¿¹ÒÖÓôÒ©£¬£¬£¬£¬£¬Ëüͨ¹ýÁ½ÖÖ²î±ðµÄ×÷ÓÃģʽ£¬£¬£¬£¬£¬ÒÖÖÆSERTµÄÔÙÉãÈ¡ºÍ¼ÓÈëµ÷Àí5-HTÊÜÌ壬£¬£¬£¬£¬×÷ÓÃÓÚÁù¸öÒ©Àíѧ°Ðµã£¨Þ׿¹5-HT3R¡¢Þ׿¹5-HT7R¡¢Þ׿¹5-HT1DR¡¢²¿·Ö¼¤¶¯5-HT1BR¡¢¼¤¶¯5-HT1AR¡¢ÒÖÖÆSERT£©Ê©Õ¹¿¹ÒÖÓôÁÆЧ¡£¡£¡£¡£ÁÙ´²Ç°Ñо¿Åú×¢£¬£¬£¬£¬£¬5-HT3¡¢5-HT7ÊÜÌåÞ׿¹×÷ÓÃÒÔ¼°5-HT1AÊÜÌ弤Ðж¯ÓÿÉÄܶ԰üÀ¨Ó°ÏóÔÚÄÚµÄÈÏÖª¹¦Ð§±¬·¢Æð¾¢Ó°Ï죬£¬£¬£¬£¬ÌáÐÑ·üÁòÎ÷Í¡¶ÔÈÏÖªÖ¢×´µÄÆð¾¢×÷Óᣡ£¡£¡£

 

2018Äê5ÔÂ2ÈÕ£¬£¬£¬£¬£¬ÃÀ¹úʳÎïÒ©Æ·¼àÊÓÖÎÀí¾Ö£¨FDA£©Í¨¹ýÁË·üÁòÎ÷Í¡µÄÒ»ÏîÔö²¹ÁÙ´²Ó¦Ó㬣¬£¬£¬£¬¼´¸ÄÉÆÒÖÓôÖ¢£¨MDD£©¼±ÐÔÆÚ»¼ÕßÈÏÖª¹¦Ð§µÄÒ»¸öÖ÷Ҫά¶È¡ª¡ªÐÅÏ¢¼Ó¹¤ËÙÂÊ£¬£¬£¬£¬£¬Õë¶ÔÒÖÓôÖ¢°éÈÏÖª¹¦Ð§ÕÏ°­µÄ»¼Õߣ¬£¬£¬£¬£¬·üÁòÎ÷Í¡ÊÇÓµÓÐI¼¶Ö¤¾ÝµÄ¿¹ÒÖÓôÒ©¡£¡£¡£¡£

 

Ò»ÏîËæ»ú¡¢Ë«Ã¤¡¢Î¿½å¼Á±ÈÕÕÑо¿£¬£¬£¬£¬£¬ÄÉÈëÀ´×Ô12¸ö¹ú¼ÒµÄ602ÃûÒÖÓôÖ¢»¼Õߣ¬£¬£¬£¬£¬»®·Ö¸øÓè·üÁòÎ÷Í¡10mg/Ìì¡¢·üÁòÎ÷Í¡20mg/Ì졢ο½å¼ÁÖÎÁÆ8ÖÜ£¬£¬£¬£¬£¬Ê¹ÓÃPDQÆÀ¹À»¼ÕßµÄÈÏÖªÖ¢×´¡£¡£¡£¡£Ð§¹ûÏÔʾ£¬£¬£¬£¬£¬·üÁòÎ÷Í¡ÏÔÖø¸ÄÉÆÒÖÓô»¼Õߵĸ÷ÏîÈÏÖªÖ¢×´[10]¡£¡£¡£¡£

ÈÏÖªÖ¢×´ÊÇÒÖÓôÖ¢µÄ½¹µãÖ¢×´Ö®Ò»£¬£¬£¬£¬£¬¿É·ºÆðÓÚÒÖÓôÖ¢ÒÖÓô±¬·¢Ç°ÇýÆÚ¡¢¼±ÐÔ±¬·¢ÆÚ¼°»º½âÆÚ£¬£¬£¬£¬£¬±»ºöÊÓµÄÈÏÖªÖ¢×´»á³ÉΪ»º½âÆÚºóµÄÖ÷Òª²ÐÁôÖ¢×´£¬£¬£¬£¬£¬Ó°ÏìÒÖÓôÖ¢»¼ÕߵĻָ´£¬£¬£¬£¬£¬²¢ÔöÌíÒÖÓôÖ¢¸´È¼¡¢¸´·¢µÄ·çÏÕ¡£¡£¡£¡£Ïà±ÈÓÚÇéÐ÷Ö¢×´£¬£¬£¬£¬£¬¶ÔÒÖÓôÖ¢»¼ÕßÈÏÖªÖ¢×´µÄÖØÊÓˮƽ»¹±£´æÏÔ×Åȱ·¦£¬£¬£¬£¬£¬ÁÙ´²ÉÏÓ¦ÖØÊÓ¶ÔÒÖÓôÖ¢»¼ÕßÈÏÖªÖ¢×´µÄʶ±ðºÍ¸ÉÔ¤¡£¡£¡£¡£·üÁòÎ÷Í¡ÊÇÒ»ÖÖ¶à°Ðµã¡¢¶àģʽµÄÐÂÐÍ¿¹ÒÖÓôÒ©£¬£¬£¬£¬£¬ÔÚ¸ÄÉÆÒÖÓôÇéÐ÷µÄͬʱ¿ÉÒÔÏÔÖø¸ÄÉÆÈÏÖªÖ¢×´£¬£¬£¬£¬£¬Ïà½ÏÓÚSSRI¡¢SNRIµÈ£¬£¬£¬£¬£¬·üÁòÎ÷Í¡ÔÚ¸ÄÉÆÈÏÖªÖ¢×´µÄÁÙ´²Ñо¿Ð§¹û¸üºÃ£¬£¬£¬£¬£¬ÇÒÆäÈÏÖªÖ¢×´¸ÄÉƵÄЧӦÊÇÖ±½ÓµÄ¡¢×ÔÁ¦ÓÚÒÖÓôÖ¢×´¸ÄÉÆ¡£¡£¡£¡£

 

²Î¿¼ÎÄÏ×

[1]Huang Y , Wang Y , Wang H ,et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2019,6(3):211-224. 

[2]ÑÖµ¤·å,ÀîÁè½­. ÒÖÓôÖ¢»¼ÕßµÄÈÏÖª¹¦Ð§ÕÏ°­¼°ÆäÁÙ´²Æôʾ£ÛJ£Ý. Öлª¾«Éñ¿ÆÔÓÖ¾, 2018,51(5):343-346. 

[3] ÖлªÒ½Ñ§»á¾«Éñҽѧ·Ö»áÒÖÓôÕÏ°­Ñо¿Ð­×÷×é. ÒÖÓôÖ¢ÈÏÖªÖ¢×´ÆÀ¹ÀÓë¸ÉԤר¼Ò¹²Ê¶[J]. Öлª¾«Éñ¿ÆÔÓÖ¾,2020,53(05)£º369-376.

[4] Conradi HJ, Ormel J, de Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011 Jun;41(6):1165-74. 

[5]Semkovska M, Quinlivan L, O'Grady T, Johnson R, Collins A, O'Connor J, Knittle H, Ahern E, Gload T. Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry. 2019 Oct;6(10):851-861.

[6]Hasselbalch BJ, Knorr U, Hasselbalch SG, Gade A, Kessing LV. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur Psychiatry. 2013 Aug;28(6):349-55.

[7]ÀîÁè½­,ÂíÐÁ. ÖйúÒÖÓôÕÏ°­·ÀÖÎÖ¸ÄÏ£ÛM£Ý. 2°æ. ±±¾©:ÖлªÒ½Ñ§µç×ÓÒôÏñ³öÊéÉç, 2015.

[8]Shilyansky C, Williams LM, Gyurak A, Harris A, Usherwood T, Etkin A. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. Lancet Psychiatry. 2016 May;3(5):425-35. 

[9]Baune BT, Brignone M, Larsen KG. A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder. Int J Neuropsychopharmacol. 2018 Feb 1;21(2):97-107. 

[10]McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014 Oct;17(10):1557-67.

 

ÌØÊâ˵Ã÷£º±¾ÎÄÄÚÈݲ¿·ÖȪԴÒÔÉϲο¼ÎÄÏ×£¬£¬£¬£¬£¬½ö×öÐÅÏ¢ÕûºÏ·ÖÏí£¬£¬£¬£¬£¬²»´ú±íÈκÎÓÃÒ©½¨Ò飬£¬£¬£¬£¬ÈôÓÐÇÖȨ¡¢ÐÅÏ¢ÓÐÎó»òÆäËûÒìÒ飬£¬£¬£¬£¬ÇëÁªÏµ918²©ÌìÌþÙÐÐɾ³ý£¡

 

¡¾ÍøÕ¾µØͼ¡¿